About Spinal muscular atrophy with respiratory distress type 2
Spinal muscular atrophy with respiratory distress type 2 is a rare disease catalogued by Orphanet (ORPHA:404521). It is associated with the LAS1L gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Spinal muscular atrophy with respiratory distress type 2 trials.
Search ClinicalTrials.gov for "Spinal muscular atrophy with respiratory distress type 2" or filter by Orphanet code ORPHA:404521 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Spinal muscular atrophy with respiratory distress type 2 trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Spinal muscular atrophy with respiratory distress type 2. Updated daily.